Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Renal cell carcinoma.
Young M, Jackson-Spence F, Beltran L, Day E, Suarez C, Bex A, Powles T, Szabados B. Young M, et al. Among authors: jackson spence f. Lancet. 2024 Aug 3;404(10451):476-491. doi: 10.1016/S0140-6736(24)00917-6. Epub 2024 Jul 18. Lancet. 2024. PMID: 39033764 Review.
Biomarkers associated with survival in patients with platinum-refractory urothelial carcinoma treated with paclitaxel.
Jackson-Spence F, Ackerman C, Jones R, Toms C, Jovaisaite A, Young M, Hussain S, Protheroe A, Birtle A, Chakraborti P, Huddart R, Jagdev S, Bahl A, Sundar S, Crabb S, Powles T, Szabados B. Jackson-Spence F, et al. Urol Oncol. 2024 Nov;42(11):372.e1-372.e10. doi: 10.1016/j.urolonc.2024.05.015. Epub 2024 Jul 17. Urol Oncol. 2024. PMID: 39025719 Clinical Trial.
Is HER2 the New NECTIN4 in Advanced Urothelial Cancer?
Nally E, Young M, Wells C, Fairhead R, Baines K, Cheney-Lowe H, Jackson-Spence F, Powles T. Nally E, et al. Among authors: jackson spence f. Eur Urol Focus. 2024 Mar;10(2):219-221. doi: 10.1016/j.euf.2024.05.018. Epub 2024 Jun 1. Eur Urol Focus. 2024. PMID: 38825408
NLR Outperforms Low Hemoglobin and High Platelet Count as Predictive and Prognostic Biomarker in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
Young M, Tapia JC, Szabados B, Jovaisaite A, Jackson-Spence F, Nally E, Powles T. Young M, et al. Among authors: jackson spence f. Clin Genitourin Cancer. 2024 Jun;22(3):102072. doi: 10.1016/j.clgc.2024.102072. Epub 2024 Mar 8. Clin Genitourin Cancer. 2024. PMID: 38615487 Free article.
Top advances of the year: Genitourinary cancer.
Jackson-Spence F, Young M, Sweeney C, Powles T. Jackson-Spence F, et al. Cancer. 2023 Sep 1;129(17):2603-2609. doi: 10.1002/cncr.34907. Epub 2023 Jun 28. Cancer. 2023. PMID: 37378532 Free article.
Baseline and Dynamic Changes in Hemoglobin Levels Predict Treatment Response and Prognosis in Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study.
Yang YH, Ansel S, Meerveld-Eggink A, Jackson-Spence F, Rallis K, Brian P, Choy J, Sng C, Adeniran P, Amin J, Galope S, Anderson N, Bex A, Powles T, Venugopal B, Szabados B. Yang YH, et al. Among authors: jackson spence f. Clin Genitourin Cancer. 2023 Aug;21(4):e242-e251. doi: 10.1016/j.clgc.2023.02.001. Epub 2023 Feb 10. Clin Genitourin Cancer. 2023. PMID: 36922286 Free article.
Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Loo Gan C, Huang J, Pan E, Xie W, Schmidt AL, Labaki C, Meza L, Bouchard G, Li H, Jackson-Spence F, Sánchez-Ruiz C, Powles T, Kumar SA, Weise N, Hall WA, Rose BS, Beuselinck B, Suarez C, Pal SK, Choueiri TK, Heng DYC, McKay RR. Loo Gan C, et al. Among authors: jackson spence f. Eur Urol Oncol. 2023 Apr;6(2):204-211. doi: 10.1016/j.euo.2022.10.004. Epub 2022 Nov 1. Eur Urol Oncol. 2023. PMID: 36328934
21 results